|
1
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regioal mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the Global
burden of disease study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xue C, Hu Z, Jiang W, Zhao Y, Xu F, Huang
Y, Zhao H, Wu J, Zhang Y, Zhao L, et al: National survey of the
medical treatment status for non-small cell lung cancer (NSCLC) in
China. Lung Cancer. 77:371–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Gu J, Roth JA, Hildebrandt MA,
Lippman SM, Ye Y, Minna JD and Wu X: Pathway-based serum microRNA
profiling and survival in patients with advanced stage non-small
cell lung cancer. Cancer Res. 73:4801–4809. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oak CH, Wilson D, Lee HJ, Lim HJ and Park
EK: Potential molecular approaches for the early diagnosis of lung
cancer (review). Mol Med Rep. 6:931–936. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Q, Xu E, Dai J, Liu B, Han Z, Wu J,
Zhang S, Peng B, Zhang Y and Jiang Y: A novel long noncoding RNA
AK001796 acts as an oncogene and is involved in cell growth
inhibition by resveratrol in lung cancer. Toxicol Appl Pharmacol.
285:79–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kesanakurti D, Maddirela DR, Chittivelu S,
Rao JS and Chetty C: Suppression of tumor cell invasiveness and in
vivo tumor growth by microRNA-874 in non-small cell lung cancer.
Biochem Biophys Res Commun. 434:627–633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cho S, Park TI, Lee EB and Son SA: Poor
prognostic factors in surgically resected stage I non-small cell
lung cancer: Histopathologic and immunohistochemical analysis.
Korean J Thorac Cardiovasc Surg. 45:101–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Esquela-Kerscher A, Trang P, Wiggins JF,
Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG and
Slack FJ: The let-7 microRNA reduces tumor growth in mouse models
of lung cancer. Cell Cycle. 7:759–764. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiang J, Wu Y, Li DS, Wang ZY, Shen Q, Sun
TQ, Guan Q and Wang YJ: miR-584 suppresses invasion and cell
migration of thyroid carcinoma by regulating the target oncogene
ROCK1. Oncol Res Treat. 38:436–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xue H, Guo X, Han X, Yan S, Zhang J, Xu S,
Li T, Guo X, Zhang P, Gao X, et al: MicroRNA-584-3p, a novel tumor
suppressor and prognostic marker, reduces the migration and
invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Oncotarget. 7:4785–4805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Q, Li Z, Wei S, Wang W, Chen Z, Zhang
L, Chen L, Li B, Sun G, Xu J, et al: Overexpression of miR-584-5p
inhibits proliferation and induces apoptosis by targeting WW
domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
J Exp Clin Cancer Res. 36:592017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Wen W, Shan X, Zhu W, Xu J, Guo R,
Cheng W, Wang F, Qi LW, Chen Y, et al: A six-microRNA panel in
plasma was identified as a potential biomarker for lung
adenocarcinoma diagnosis. Oncotarget. 8:6513–6525. 2017.PubMed/NCBI
|
|
17
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roberto GM, Delsin LEA, Vieira GM, Silva
MO, Hakime RG, Gava NF, Engel EE, Scrideli CA, Tone LG and
Brassesco MS: ROCK1-predictedmicroRNAs dysregulation contributes to
tumor progression in ewing sarcoma. Pathol Oncol Res.
21–Dec;2017.(Epub ahead of print). View Article : Google Scholar
|
|
20
|
Cipolla GA, Park JK, de Oliveira LA,
Lobo-Alves SC, de Almeida RC, Farias TD, Lemos Dde S, Malheiros D,
Lavker RM and Petzl-Erler ML: A 3′UTR polymorphism marks
differential KLRG1 mRNA levels through disruption of a miR-584-5p
binding site and associates with pemphigus foliaceus
susceptibility. Biochim Biophys Acta 1859. 1306–1313. 2016.
|
|
21
|
Chun TH, Sabeh F, Ota I, Murphy H,
McDonagh KT, Holmbeck K, Birkedal-Hansen H, Allen ED and Weiss SJ:
MT1-MMP-dependent neovessel formation within the confines of the
three-dimensional extracellular matrix. J Cell Biol. 167:757–767.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sabeh F, Ota I, Holmbeck K,
Birkedal-Hansen H, Soloway P, Balbin M, Lopez-Otin C, Shapiro S,
Inada M, Krane S, et al: Tumor cell traffic through the
extracellular matrix is controlled by the membrane-anchored
collagenase MT1-MMP. J Cell Biol. 167:769–781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tolde O, Rösel D, Mierke CT, Panková D,
Folk P, Vesely P and Brábek J: Neoplastic progression of the human
breast cancer cell line G3S1 is associated with elevation of
cytoskeletal dynamics and upregulation of MT1-MMP. Int J Oncol.
36:833–839. 2010.PubMed/NCBI
|
|
24
|
Wang YZ, Wu KP, Wu AB, Yang ZC, Li JM, Mo
YL, Xu M, Wu B and Yang ZX: MMP-14 overexpression correlates with
poor prognosis in non-small cell lung cancer. Tumor Biol.
35:9815–9821. 2014. View Article : Google Scholar
|
|
25
|
Zhou H, Wu A, Fu W, Lv Z and Zhang Z:
Significance of semaphorin-3A and MMP-14 protein expression in
non-small cell lung cancer. Oncol Lett. 7:1395–1400. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiang X, Mei H, Qu H, Zhao X, Li D, Song
H, Jiao W, Pu J, Huang K, Zheng L and Tong Q: miRNA-584-5p exerts
tumor suppressive functions in human neuroblastoma through
repressing transcription of matrix metalloproteinase 14. Biochim
Biophys Acta 1852. 1743–1754. 2015.
|
|
27
|
Fils-Aimé N, Dai M, Guo J, El-Mousawi M,
Kahramangil B, Neel JC and Lebrun JJ: MicroRNA-584 and the protein
phosphatase and actin regulator 1 (PHACTR1), a new signaling route
through which transforming growth factor-β mediates the migration
and actin dynamics of breast cancer cells. J Biol Chem.
288:11807–11823. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ueno K, Hirata H, Shahryari V, Chen Y,
Zaman MS, Singh K, Tabatabai ZL, Hinoda Y and Dahiya R: Tumour
suppressor microRNA-584 directly targets oncogene Rock-1 and
decreases invasion ability in human clear cell renal cell
carcinoma. Br J Cancer. 104:308–315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang L, Yuan J, Tu Y, Mao X, He S, Fu G,
Zong J and Zhang Y: Co-expression of MMP-14 and MMP-19 predicts
poor survival in human glioma. Clin Transl Oncol. 15:139–145. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xie H, Xue YX, Liu LB, Wang P, Liu YH and
Ying HQ: Expressions of matrix metalloproteinase-7 and matrix
metalloproteinase-14 associated with the activation of
extracellular signal-regulated kinase1/2 in human brain gliomas of
different pathological grades. Med Oncol. 28 Suppl 1:S433–S438.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kraljevic Pavelic S, Sedic M, Bosnjak H,
Spaventi S and Pavelic K: Metastasis: New perspectives on an old
problem. Mol Cancer. 10:222011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sohn EJ, Jung DB, Lee H, Han I, Lee J, Lee
H and Kim SH: CNOT2 promotes proliferation and angiogenesis via
VEGF signaling in MDA-MB-231 breast cancer cells. Cancer Lett.
412:88–98. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shao S and Zhao X, Zhang X, Luo M, Zuo X,
Huang S, Wang Y, Gu S and Zhao X: Notch1 signaling regulates the
epithelial-mesenchymal transition and invasion of breast cancer in
a Slug-dependent manner. Mol Cancer. 14:282015. View Article : Google Scholar : PubMed/NCBI
|
